CROI 2019 Abstract eBook
Abstract eBook
Keyword Index
Respondent-driven sampling (RDS) 852 Resting memory CD4 T cells 189, 368 Resting state functional connectivity 457 Restricted mean survival time 509
SIV/HIV pathogenesis 199 SIVmac251 294 Skeletal muscle 701
Telmisartan 300 Telomere 258
Telomere length 258, 314 Template switching 169
Sleep apnea 662 Sleep quality 662 SLFN14 175 Smoking 31, 214, 685, 1044 Social 212 Social determinants of health 1039 Social network 1048 Socioeconomic status 645, 663 Sofosbuvir 469 Soluble biomarkers 247 South Africa 54, 268, 525, 531, 538, 721, 763, 765, 818, 913, 919, 981, 1007, 1059 Southern Africa 625, 995, 1030, 1085
Restriction factor 69, 772 Resuppression 905, 1061 Retention 996, 997, 1032 Retention in care 53, 763, 903, 1017, 1028, 1050, 1052, 1055, 1071 Retinol binding protein 695 Revaccination 622 Reverse transcription 169 Rifampicin 78 Rifampicin-resistant tuberculosis 719 Rifampin 81, 738 Rifapentine 80 RIG-I 260 Rilpivirine 139, 140, 692 Risk • Compensation 948, 950 • Factors 83, 237, 577, 603, 846, 899, 920 • HIV infection 937, 975, 979
Temporal study 591 Temporal trends 149 Tenofovir 229, 462, 626, 627, 691, 766 Tenofovir alafenamide 101, 102, 103, 104, 127, 463, 487, 506, 519, 546, 552, 639, 651, 652, 693, 694, 696 Tenofovir detection 992 Tenofovir disoproxil fumarate 103, 104, 127, 477, 490, 506, 629, 639, 651, 652, 686, 688, 689, 694, 695, 960
Tenofovir PrEP 478, 992 Tenofovir-monoester 477 Test and start 1017 Test and treat 149, 1023, 1024, 1092 Test-seeking behavior 935 Testing 49, 150, 584, 589, 774, 925 Testing coverage 95, 896
Space-time analysis 600 Spatial analysis 873, 874 Spatial autocorrelation 94 sPD-L1 247 Specificity 554 Sphingosine-1-phosphate 379 Spirometry 811 Splicing 614 Src family kinase 193 Statins 649 STD clinic 962, 983
Testing pattern 957 TFV-DP 462, 463, 657 TGW 104 Th1 cells 203 Th17 209 Th17 cells 203, 301
• Perception 980 • Prediction 128 • Score 1085
Ritonavir 468, 641 Ritonavir-boosted protease inhibitor 81, 467 RNA 150, 557
Th22 cells 203 Thailand 522 Therapeutic strategies 267 Thromboembolism 636 Thrombosis 636 Thymic output 809 Thymidine analogues 676 Tight junction 228 TIGIT 254
Stem cell transplantation 29 Stigma and discrimination 898 Stillbirth 754 Stimulant use 1062 sTNF-RII 643 Streamlined care 138 Strength 702 Streptococcus 713 Stress 212 Structural protein 177 Structure 186, 195 Stunting 810 Sub-Saharan Africa 93, 646, 833, 904, 910, 928, 948, 949, 1020, 1063, 1084, 1091 Subclinical atherosclerosis 635 Subcutaneous injection 486 Subsets 368 Substance use 418, 819, 880, 884, 889, 890, 921 Superinfection 226 Suppression 44, 1048 Suppressive ART 246 Surveillance 107, 663, 743, 834, 857, 941, 942, 1031 Surveillance data 881, 897, 1057, 1078 Survival 16, 894, 909, 914 Sustained virologic response 568 SVR12 578 Swaziland 537 Switch 552, 669 Switching regimen 151, 493, 674 Syphilis 47, 839, 855, 1012, 1013, 1014, 1015, 1071 Systematic review and meta-analysis 588 Systemic inflammation 822 Systems biology 70, 185 T cell 222, 255, 300, 316, 363, 393, 479 • Activation 319, 369, 385 • Exhaustion 215, 351 • Homeostasis 571 • Migration 221 • Profiling 319 • Receptor repertoire 317, 809 • Response 259, 508, 728 • Subsets 207, 209, 215, 238, 323, 333, 803 T follicular helper cells 133, 199, 266, 319, 320, 343, 344, 381, 801 T follicular regulatory 197 T regulatory cells 197, 207, 238, 259, 321, 322 Talaromycosis 706, 710, 711 Tanzania 832, 842 Task shifting 53, 588 Tat 417, 653 Tec-family kinases 192, 193 Telecommunication services 587 Telehealth 955 Subtype C 532, 540 Subtypes 507, 942 Sudden arrhythmic death 33 Sudden cardiac death 32, 33 Suicide 893, 921
RNA packaging 178 RNA polymerase 260 RNA seq 264, 270, 658 Romidepsin 26, 397, 438
Rural 886, 955 RV144 293, 320 Rwanda 1035 Ryan White HIV/AIDS program 1039, 1065 Safety 81, 519, 560, 830 Safety-net clinic 515 Same day therapy 515, 1025 SAMHD1 171, 174 Sanger 537 Scale-up 98, 1075, 1080, 1081
Time from diagnosis to first viral suppression 153 Time from HIV infection to diagnosis 153, 865 Time to ART initiation 1018, 1021 Timing 375 Tissue 200, 334, 479
Tissue factor 644 TLR7 agonist 370 Toll-like receptor 4 235 Total HIV-1 DNA 389 Toxicity 437
Screening 290, 305, 579, 583, 584, 585, 586, 706, 850, 851 Second-line antiretroviral treatment 144, 496, 498 Second-line failure 531 Selection bias 413 Self-testing 777, 926, 931, 935, 937, 1080, 1081 Semen 392, 402 Seminal viral load 524 Seopositivity 269 Sepsis 31 Sequencing 340, 507, 543 Sequencing data 526 SERINC5 190, 194 Seroconversion 239, 832 Serodiscordant couples 923, 948, 950 Serological 622, 837, 923, 941 Set-point viral load 1092 Sex differences and s ex-specific analyses 128, 252, 384, 516, 518, 663, 673, 916 Sex networks 841 Sex work 840, 981, 1091 Sex workers 949, 958, 959, 1006, 1084 Sexual health 853 Sexual networks 843, 1084, 1091 Sexual risk behavior 846, 887, 948, 950, 1002 Sexual transmission 849, 984 Sexual violence 840 Sexually transmitted infection 47, 49, 599, 849, 850, 851, 925, 927, 965, 966, 967, 968, 969, 1002, 1003, 1004, 1005, 1011, 1013 SHIMS2 951 SHIV 100, 101, 223, 427, 428, 800, 969, 970 Shock and kill 361 Simplification 494 Simulation 1088 Single cell analysis 89, 91, 187, 308, 387, 400 Single copy assay 384, 557 Single genome sequencing 338 Single nucleotide polymorphism 633 Single template HIV-1 full-genome sequencing 135 Single-tablet regimen 46, 511 SIV 22, 24, 132, 133, 170, 199, 209, 212, 233, 295, 352, 390, 429, 432 SIV Nef 137, 193
TRAIL 632, 1088 Trajectory 1069
Trajectory analysis 820 Transactional sex 1074 Transcription 175, 381
Transcription silencing 378 Transcriptional profile 397 Transcriptionally active proviruses 330, 385 Transcriptome 183, 277, 297, 313, 332 Transgender 852 Transgender men 1039 Transgender women 529, 841, 939, 973, 981, 988, 989 Transition to adolescence 807 Translational value 212 Transmission 166, 725 Transmission cluster 533, 591, 597, 870, 891 Transmission dynamics 1084 Transmission network 833, 875, 876 Transmission risk 524, 862 Transmitted drug resistance 526, 529, 870, 876 Transplantation 336, 605 Transporters 470 Trauma surgery 579 Treat all 1016, 1022, 1023, 1052 Treated HIV infection 197 Treatment 145, 501, 583, 589, 700 • As prevention 92, 97, 1029, 1056, 1060 • Continuum 852, 1035 • Experienced 483, 485, 671 • Failure 905 • Initiation 1018, 1024, 1051 • Interruption 391, 809 • Naïve adults 490, 537, 670 • Outcomes 507 • Scale up 95 • Strategies 506, 693, 1090 Trends 844, 848 Treponema pallidum 855 Trispecific antibody 28
Keyword Index
Tropism 225, 249 Tryptophan 602
CROI 2019 464
Made with FlippingBook - Online Brochure Maker